{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:51:07Z","timestamp":1781747467700,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1L60A1194399"],"award-info":[{"award-number":["1L60A1194399"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI124413"],"award-info":[{"award-number":["R01AI124413"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001465","name":"American Thoracic Society","doi-asserted-by":"publisher","award":["PG014635-01"],"award-info":[{"award-number":["PG014635-01"]}],"id":[{"id":"10.13039\/100001465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003442","name":"Stony Wold-Herbert Fund","doi-asserted-by":"publisher","award":["PT24-4036"],"award-info":[{"award-number":["PT24-4036"]}],"id":[{"id":"10.13039\/100003442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["PG014684"],"award-info":[{"award-number":["PG014684"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001312","name":"Charles H. Revson Foundation","doi-asserted-by":"publisher","award":["PG014684"],"award-info":[{"award-number":["PG014684"]}],"id":[{"id":"10.13039\/100001312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13401-8","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:54:50Z","timestamp":1777532090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Socio-ecological vulnerability subgroups predict adherence and treatment outcomes in multidrug-resistant tuberculosis and HIV: a latent class analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Kevin J.","family":"Guzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubeshan","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Resha","family":"Boodhram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boitumelo","family":"Seepamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Rivet","family":"Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Zelnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Daftary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesri","family":"Padayatchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kogieleum","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"13401_CR1","unstructured":"Global Tuberculosis Report 2024, 1st ed (Geneva: World Health Organization, 2024) [accessed January 28th, 2025]. Available from: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024"},{"issue":"25","key":"13401_CR2","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1056\/NEJMoa2117166","volume":"387","author":"BT Nyang\u2019wa","year":"2022","unstructured":"Nyang\u2019wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, et al. TB-PRACTECAL Study Collaborators. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis. N Engl J Med. 2022;387(25):2331\u201343.","journal-title":"N Engl J Med"},{"issue":"10","key":"13401_CR3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","volume":"382","author":"F Conradie","year":"2020","unstructured":"Conradie F, Diacon A, Ngubane N, Howell P, Everitt D, Crook A, et al. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. N Engl J Med. 2020;382(10):893\u2013902.","journal-title":"N Engl J Med"},{"issue":"9","key":"13401_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa2119430","volume":"387","author":"F Conradie","year":"2022","unstructured":"Conradie F, Bagdasaryan T, Borisov S, Howell P, Mikiashvili L, Ngubane N, et al. Bedaquiline\u2013Pretomanid\u2013Linezolid Regimens for Drug-Resistant Tuberculosis. N Engl J Med. 2022;387(9):810\u201323.","journal-title":"N Engl J Med"},{"issue":"10","key":"13401_CR5","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.5588\/ijtld.20.0048","volume":"24","author":"N Padayatchi","year":"2020","unstructured":"Padayatchi N, Bionghi N, Osman F, Naidu N, Ndjeka N, Master I. Treatment outcomes in patients with drug-resistant TB-HIV co-infection treated with bedaquiline and linezolid. Int J Tuberc Lung Dis. 2020;24(10):1024\u201331.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"13401_CR6","first-page":"1081","volume":"29","author":"J Miller","year":"2023","unstructured":"Miller J, Rimmer S, Nimmo C, O\u2019Donnell M. Therapeutic failure and acquired bedaquiline and delamanid resistance in treatment of drug-resistant TB. Emerg Infect Dis. 2023;29(5):1081\u20134.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"13401_CR7","doi-asserted-by":"publisher","first-page":"1800353","DOI":"10.1183\/13993003.00353-2018","volume":"54","author":"IF Walker","year":"2019","unstructured":"Walker IF, Shi O, Hicks JP, Elsey H, Wei X, Menzies D, et al. Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients. Eur Respir J. 2019;54(1):1800353.","journal-title":"Eur Respir J"},{"issue":"1","key":"13401_CR8","doi-asserted-by":"publisher","first-page":"e010592","DOI":"10.1136\/bmjgh-2022-010592","volume":"8","author":"AL Oh","year":"2023","unstructured":"Oh AL, Makmor-Bakry M, Islahudin F, Wong IC. Prevalence and predictive factors of tuberculosis treatment interruption in the Asia region: a systematic review and meta-analysis. BMJ Glob Health. 2023;8(1):e010592.","journal-title":"BMJ Glob Health"},{"issue":"1","key":"13401_CR9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41598-021-04742-2","volume":"12","author":"Q Suliman","year":"2022","unstructured":"Suliman Q, Lim PY, Md Said S, Tan KA, Mohd Zulkefli NA. Risk factors for early TB treatment interruption among newly diagnosed patients in Malaysia. Sci Rep. 2022;12(1):745.","journal-title":"Sci Rep"},{"issue":"10","key":"13401_CR10","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.socscimed.2012.01.027","volume":"74","author":"A Daftary","year":"2012","unstructured":"Daftary A. HIV and tuberculosis: the construction and management of double stigma. Soc Sci Med. 2012;74(10):1512\u20139.","journal-title":"Soc Sci Med"},{"issue":"1","key":"13401_CR11","doi-asserted-by":"publisher","first-page":"1801030","DOI":"10.1183\/13993003.01030-2018","volume":"53","author":"S Law","year":"2019","unstructured":"Law S, Daftary A, O\u2019Donnell M, Padayatchi N, Calzavara L, Menzies D. Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review. Eur Respir J. 2019;53(1):1801030.","journal-title":"Eur Respir J"},{"issue":"7","key":"13401_CR12","doi-asserted-by":"publisher","first-page":"e1002595","DOI":"10.1371\/journal.pmed.1002595","volume":"15","author":"N Alipanah","year":"2018","unstructured":"Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, Nahid P. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLoS Med. 2018;15(7):e1002595.","journal-title":"PLoS Med"},{"issue":"1","key":"13401_CR13","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1097\/CCM.0000000000004710","volume":"49","author":"P Sinha","year":"2021","unstructured":"Sinha P, Calfee CS, Delucchi KL. Practitioner\u2019s Guide to Latent Class Analysis: Methodological Considerations and Common Pitfalls. Crit Care Med. 2021;49(1):e63\u201379.","journal-title":"Crit Care Med"},{"issue":"8","key":"13401_CR14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","volume":"2","author":"CS Calfee","year":"2014","unstructured":"Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA. NHLBI ARDS Network. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2(8):611\u201320.","journal-title":"Lancet Respir Med"},{"issue":"11","key":"13401_CR15","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1164\/rccm.202105-1302OC","volume":"204","author":"P Sinha","year":"2021","unstructured":"Sinha P, Furfaro D, Cummings MJ, Abrams D, Delucchi K, Maddali MV, et al. Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids. Am J Respir Crit Care Med. 2021;204(11):1274\u201385.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"13401_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S2213-2600(23)00237-0","volume":"11","author":"P Sinha","year":"2023","unstructured":"Sinha P, Kerchberger VE, Willmore A, Chambers J, Zhuo H, Abbott J, et al. Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. Lancet Respir Med. 2023;11(11):965\u201374.","journal-title":"Lancet Respir Med"},{"issue":"12","key":"13401_CR17","doi-asserted-by":"publisher","first-page":"e2029068","DOI":"10.1001\/jamanetworkopen.2020.29068","volume":"3","author":"RW Grant","year":"2020","unstructured":"Grant RW, McCloskey J, Hatfield M, Uratsu C, Ralston JD, Bayliss E, Kennedy CJ. Use of Latent Class Analysis and k-Means Clustering to Identify Complex Patient Profiles. JAMA Netw Open. 2020;3(12):e2029068.","journal-title":"JAMA Netw Open"},{"key":"13401_CR18","doi-asserted-by":"publisher","first-page":"e479","DOI":"10.1016\/S2214-109X(20)30548-9","volume":"9","author":"A Daftary","year":"2021","unstructured":"Daftary A, Mondal S, Zelnick J, Friedland G, Seepamore B, Boodhram R, et al. Dynamic Needs and Challenges of People with Drug-Resistant Tuberculosis in South Africa: a Qualitative Study. Lancet Glob Health. 2021;9:e479\u201388.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"13401_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/QAI.0000000000002940","volume":"90","author":"MR O\u2019Donnell","year":"2022","unstructured":"O\u2019Donnell MR, Padayatchi N, Wolf A, Zelnick J, Daftary A, Orrell C, et al. Bedaquiline Adherence Measured by Electronic Dose Monitoring Predicts Clinical Outcomes in the Treatment of Patients With Multidrug-Resistant Tuberculosis and HIV\/AIDS. J Acquir Immune Defic Syndr. 2022;90(3):325\u201332.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"13401_CR20","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/cid\/ciac232","volume":"75","author":"M Bateman","year":"2022","unstructured":"Bateman M, Wolf A, Chimukangara B, Brust JCM, Lessells R, Amico R, et al. Adherence Measured Using Electronic Dose Monitoring is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus\/AIDS and Multidrug-Resistant Tuberculosis. Clin Infect Dis. 2022;75(9):1489\u201396.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"13401_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/pubmed\/fdae018","volume":"46","author":"G Marme","year":"2024","unstructured":"Marme G, Kuzma J, Zimmerman P, Harris N, Rutherford S. Investigating socio-ecological factors influencing implementation of tuberculosis infection prevent and control in rural Papua New Guinea. J Pulic Health (Oxf). 2024;46(2):267\u201376.","journal-title":"J Pulic Health (Oxf)"},{"issue":"4","key":"13401_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/10705510701575396","volume":"14","author":"KL Nylund","year":"2007","unstructured":"Nylund KL, Asparouhov T, Muth\u00e9n BO. Deciding on the Number of Classes in Latent Class Analysis and Growth Mixture Modeling: A Monte Carlo Simulation Study. Struct Equ Model. 2007;14(4):535\u201369.","journal-title":"Struct Equ Model"},{"issue":"4","key":"13401_CR23","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.csda.2004.11.004","volume":"50","author":"CC Yang","year":"2006","unstructured":"Yang CC. Evaluating Latent Class Analysis Models in Qualitative Phenotype Identification. Comput Stat Data Anal. 2006;50(4):1090\u2013104.","journal-title":"Comput Stat Data Anal"},{"key":"13401_CR24","unstructured":"Definitions and reporting frameworks for tuberculosis \u2013. 2013 revisions (updated December 2014 and January 2020) [accessed March 4th, 2025]. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/79199\/9789241505345_eng.pdf?sequence=1"},{"issue":"11","key":"13401_CR25","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41591-018-0224-2","volume":"24","author":"MZ Imperial","year":"2018","unstructured":"Imperial MZ, Nahid P, Phillips PPJ, Davies G, Fielding K, Hanna D, et al. A Patient-Level Pooled Analysis of Treatment-Shortening Regimens for Drug-Susceptible Pulmonary Tuberculosis. Nat Med. 2018;24(11):1708\u201315.","journal-title":"Nat Med"},{"issue":"3","key":"13401_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/QAI.0000000000002142","volume":"82","author":"KK Byrd","year":"2019","unstructured":"Byrd KK, Hou JG, Hazen RJ, Hanna DB, Xu Y, Skarbinski J, et al. Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data. J Acquir Immune Defic Syndr. 2019;82(3):245\u201351.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"13401_CR27","unstructured":"Targeted regimen profiles for tuberculosis treatment, update (World Health Organization. 2023, 2023) [Accessed March 25th, 2025]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240081512"},{"issue":"5","key":"13401_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.11648\/j.ajtas.20241305.13","volume":"13","author":"V Lumumba","year":"2024","unstructured":"Lumumba V, Kariuki J, Kiplang\u2019at A, Kamau S, Mutinda B, Okeyo S, et al. Comparative Analysis of Cross-Validation Techniques: LOOCV, K-Folds Cross-Validation, and Repeated K-Folds Cross-Validation in Machine Learning Models. Am J Theor Appl Stat. 2024;13(5):127\u201337.","journal-title":"Am J Theor Appl Stat"},{"issue":"7","key":"13401_CR29","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1109\/TNNLS.2018.2878400","volume":"30","author":"M Bader-El-Den","year":"2019","unstructured":"Bader-El-Den M, Teitei E, Perry T. Biased Random Forest for Dealing with the Class Imbalance Problem. IEEE Trans Neural Netw Learn Syst. 2019;30(7):2163\u201372.","journal-title":"IEEE Trans Neural Netw Learn Syst"},{"issue":"1","key":"13401_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/QAI.0000000000003394","volume":"96","author":"K Reis","year":"2024","unstructured":"Reis K, Patel P, Singh N, McCallum H, Tiam A, Metcalfe J, et al. Brief Report: Differentiated Service Delivery Framework for People With Multidrug-Resistant Tuberculosis and HIV Coinfection. J Acquir Immune Defic Syndr. 2024;96(1):34\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"13401_CR31","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1186\/s13063-023-07520-9","volume":"24","author":"J Ross","year":"2023","unstructured":"Ross J, Nachega JB, Haberer JE, Mncube S, Amico KR, Marais BJ, et al. Adaptive Evaluation of mHealth and Conventional Adherence Support Interventions to Optimize Outcomes with New Treatment Regimens for Drug-Resistant Tuberculosis and HIV in South Africa (ADAP-TIV): Study Protocol for an Adaptive Randomized Controlled Trial. Trials. 2023;24(1):776.","journal-title":"Trials"},{"issue":"Suppl 6","key":"13401_CR32","doi-asserted-by":"publisher","first-page":"e25809","DOI":"10.1002\/jia2.25809","volume":"24","author":"CH Tran","year":"2021","unstructured":"Tran CH, Moore BK, Pathmanathan I, Lungu P, Shah NS, Oboho I, et al. Tuberculosis treatment within differentiated service delivery models in global HIV\/TB programming. J Int AIDS Soc. 2021;24(Suppl 6):e25809.","journal-title":"J Int AIDS Soc"},{"issue":"11","key":"13401_CR33","doi-asserted-by":"publisher","first-page":"e0277078","DOI":"10.1371\/journal.pone.0277078","volume":"17","author":"S Huddart","year":"2022","unstructured":"Huddart S, Wang M, Saludar NR, Arcalas-Po C, Woo J, Sintchenko V, et al. Adherence Trajectory as an On-Treatment Risk Indicator among Drug-Resistant TB Patients in the Philippines. PLoS One. 2022;17(11):e0277078.","journal-title":"PLoS One"},{"issue":"7","key":"13401_CR34","doi-asserted-by":"publisher","first-page":"e1901","DOI":"10.1093\/cid\/ciaa1557","volume":"73","author":"JR Zelnick","year":"2021","unstructured":"Zelnick JR, Gupta-Wright A, Corbett EL, Mwaura PM, Walker IF, Chiti S, et al. Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-Resistant Tuberculosis and Human Immunodeficiency Virus. Clin Infect Dis. 2021;73(7):e1901\u201310.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"13401_CR35","first-page":"e28519","volume":"14","author":"AT Deshkar","year":"2022","unstructured":"Deshkar AT, Shirure PA. Bedaquiline: A Novel Diarylquinoline for Multidrug-Resistant Pulmonary Tuberculosis. Cureus. 2022;14(8):e28519.","journal-title":"Cureus"},{"key":"13401_CR36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s11482-018-9640-1","volume":"14","author":"M Rzeszutek","year":"2018","unstructured":"Rzeszutek M, Gruszcynska E, Firlag-Burkacka E. Soci-medical and personality correlates of psychological well-being among people living with HIV: a latent profile analysis. Appl Res Qual Life. 2018;14:1113\u201327.","journal-title":"Appl Res Qual Life"},{"issue":"2","key":"13401_CR37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10461-023-04253-3","volume":"28","author":"L Nevendorff","year":"2024","unstructured":"Nevendorff L, Pedrana A, Bourne A, Traeger M, Sindunata E, Reswana WA, et al. Characterizing socioecological markers of differentiated HIV risk amoung men who have sex with men in Indonesia. AIDS Behav. 2024;28(2):657\u201368.","journal-title":"AIDS Behav"},{"key":"13401_CR38","doi-asserted-by":"crossref","unstructured":"Murugan Y, Patel V, Acharya Y, Chokshi V, Iyer S, Sharma R, et al. Mental health impacts of multidrug-resistant tuberculosis in patients and household contacts: a mixed methods study. Cureus 2024 May 16.","DOI":"10.7759\/cureus.60412"},{"issue":"1","key":"13401_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/ijcm.IJCM_813_21","volume":"47","author":"R Sharma","year":"2022","unstructured":"Sharma R, Patel R, Shah N, Bhatt K, Mehta P, Jain A, et al. Prevalence and Determinants of Depression among Multi Drug Resistant (MDR) TB Cases Registered under National Tuberculosis Elimination Program in Ahmedabad City. Indian J Community Med. 2022;47(1):45\u20139.","journal-title":"Indian J Community Med"},{"issue":"10","key":"13401_CR40","doi-asserted-by":"publisher","first-page":"e0000989","DOI":"10.1371\/journal.pgph.0000989","volume":"2","author":"I Foster","year":"2022","unstructured":"Foster I, White L, Brown T, Andrews E, McLeod S, Taylor M, et al. Analysing Interventions Designed to Reduce Tuberculosis-Related Stigma: A Scoping Review. PLOS Glob Public Health. 2022;2(10):e0000989.","journal-title":"PLOS Glob Public Health"},{"issue":"5","key":"13401_CR41","doi-asserted-by":"publisher","first-page":"e001018","DOI":"10.1136\/bmjgh-2018-001018","volume":"3","author":"R Subbaraman","year":"2018","unstructured":"Subbaraman R, de Mondesert L, Muslimenta A, Pai M, Mayer KH, Thomas BE, Harberer J. Digital adherence technologies for the management of tubercuolosis therapy: mapping the landscape and research priorities. BMJ Glob Health. 2018;3(5):e001018.","journal-title":"BMJ Glob Health"},{"key":"13401_CR42","doi-asserted-by":"publisher","unstructured":"Te Riele JB, Buser V, Calligaro G, Esmail A, Theron G, Lesosky M, Dheda K. Relationship between chest radiographic characteristics, sputum bacterial load, and treatment outcomes in patients with extensively drug-resistant tuberculosis. Int J Infect Dis. 2019;79:65\u201371. https:\/\/doi.org\/10.1016\/j.ijid.2018.10.026. Epub 2018 Nov 3. PMID: 30395979.","DOI":"10.1016\/j.ijid.2018.10.026"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13401-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13401-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13401-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:53:43Z","timestamp":1781744023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13401-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13401"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13401-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Biomedical Research Ethics Committee of the University of KwaZulu-Natal (UKZN), South Africa, and by the Institutional Review Board of Columbia University Irving Medical Center. All participants provided written informed consent before enrollment in the study. Consent procedures were conducted in accordance with the ethical standards of the Helsinki Declaration and local regulatory requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1164"}}